Cargando…
Modeling Blood–Brain Barrier Permeability to Solutes and Drugs In Vivo
Our understanding of the pharmacokinetic principles governing the uptake of endogenous substances, xenobiotics, and biologicals across the blood–brain barrier (BBB) has advanced significantly over the past few decades. There is now a spectrum of experimental techniques available in experimental anim...
Autor principal: | Bickel, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414534/ https://www.ncbi.nlm.nih.gov/pubmed/36015323 http://dx.doi.org/10.3390/pharmaceutics14081696 |
Ejemplares similares
-
A Quasi-Physiological Microfluidic Blood-Brain Barrier Model for Brain Permeability Studies
por: Noorani, Behnam, et al.
Publicado: (2021) -
Towards Novel Biomimetic In Vitro Models of the Blood–Brain Barrier for Drug Permeability Evaluation
por: Mármol, Inés, et al.
Publicado: (2023) -
Blood-brain barrier permeability and physical exercise
por: Małkiewicz, Marta A., et al.
Publicado: (2019) -
Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?
por: Prashanth, Archana, et al.
Publicado: (2021) -
Drug delivery strategies to enhance the permeability of the blood–brain barrier for treatment of glioma
por: Zhang, Fang, et al.
Publicado: (2015)